Home:
Educational
Supplement: Section 1
SELECT PUBLICATIONS
THE
EARLY BREAST CANCER TRIALISTS' COLLABORATIVE GROUP Web
link
Collins R, Gray
R, Godwin J, Peto R. Avoidance of large biases and large random
errors in the assessment of moderate treatment effects: the need
for systematic overviews. Stat Med 1987;6: 245-250. Abstract
Early Breast
Cancer Trialists' Collaborative Group. Effects of adjuvant tamoxifen
and of cytotoxic therapy on mortality in early breast cancer: An
overview of 61 randomized trials among 28,896 women. N Engl
J Med 1988;319:1681-1691. Abstract
Early Breast
Cancer Trialists' Collaborative Group. Treatment of early breast
cancer. Vol. I: Worldwide evidence 1985-1990. Oxford University
Press 1990 Abstract
Early Breast
Cancer Trialists' Collaborative Group. Systemic treatment of
early breast cancer by hormonal, cytotoxic or immune therapy: 133
randomised trials involving 31,000 recurrences and 24,000 deaths
among 75,000 women. Lancet 1992;339:1-15 & 71-85.
Abstract
Early Breast
Cancer Trialists' Collaborative Group. Effects of radiotherapy
and surgery in early breast cancer: An overview of the randomized
trials. N Engl J Med 1995;333:1444-1455. Abstract
Early Breast
Cancer Trialists' Collaborative Group. Ovarian ablation in early
breast cancer: Overview of the randomised trials. Lancet
1996;348:1189-1196. Abstract
Early Breast
Cancer Trialists' Collaborative Group. Tamoxifen for early breast
cancer: An overview of the randomised trials. Lancet 1998;351:1451-1467.
Abstract
Early Breast
Cancer Trialists' Collaborative Group. Polychemotherapy for early
breast cancer: an overview of the randomised trials. Lancet
1998;352:930-942. Abstract
Early Breast
Cancer Trialists' Collaborative Group. Favourable and unfavourable
effects on long-term survival of radiotherapy for early breast cancer:
An overview of the randomised trials. Lancet 2000;355(9217):1757-70.
Abstract
Top
CLINICAL
TRIALS
Adams J et al.
Recruiting older adults for clinical trials. Control Clin
Trials 1997;18(1):14-26. Abstract
Albrecht TL
et al. Strategic physician communication and oncology clinical
trials. J Clin Oncol 1999;17:3324-3332. Abstract
Antman KH.
Randomized trials of high-dose chemotherapy for breast cancer.
Biochem Biophys Acta 2001;1471(3):M89-98. Abstract
Baum M, Houghton
J. Contribution of randomised controlled trials to understanding
and management of early breast cancer. Br Med J 1999;319:568-571.
Abstract
Belanger D et
al. How American oncologists treat breast cancer: An assessment
of the influence of clinical trials. J Clin Oncol 1991;9:7-16.
Abstract
Chirikos TN
et al. Impact of clinical trials on the cost of cancer care.
Med Care 2001;39(4):373-83. Abstract
Cox K. Enhancing
cancer clinical trial management: Recommendations from a qualitative
study of trial participants' experiences. Psychooncology
2000;9(4):314-22. Abstract
Daugherty CK.
Impact of therapeutic research on informed consent and the ethics
of clinical trials: A medical oncology perspective. J Clin
Oncol 1999;17(5):1601-17. Abstract
Ellis PM.
Attitudes towards and participation in randomised clinical trials
in oncology: A review of the literature. Ann Oncol
2000;11(8):939-45. Abstract
Ellis PM et
al. Randomized clinical trials in oncology: Understanding and
attitudes predict willingness to participate. J Clin Oncol
2001;19:3554-3561. Abstract
Fallowfield
L et al. Clinicians' attitudes to clinical trials of cancer therapy.
Eur J Cancer 1997;33(13):2221-2229. Abstract
Fireman BH et
al. Cost of care for patients in cancer clinical trials.
J Natl Cancer Inst 2000;92:136-142. Abstract
Fleissig A et
al. Results of an inter vention study to improve communication
about randomised clinical trials of cancer therapy. Eur J
Cancer 2001;37(3):322-31. Abstract
Giuliano AR
et al. Participation of minorities in cancer research: The influence
of structural, cultural and linguistic factors. Ann Epidemiol
2000;10(8 Suppl):S22-34. Abstract
Grant CH 3rd
et al. Patients' perceptions of physicians communication and
outcomes of the accrual to trial process. Health Commun 2000;12(1):23-39.
Abstract
Hutchins LF
et al. Underrepresentation of patients 65 years of age or older
in cancer-treatment trials. N Engl J Med 1999;341:2061-7.
Abstract
Kemeny M et
al. Barriers to participation of older women with breast cancer
in clinical trials. Proc ASCO 2000; Abstract
2371.
Lara PN et al.
Prospective evaluation of cancer clinical trial accrual patterns:
Identifying potential barriers to enrollment. J Clin Oncol
2001;19:1728-1733. Abstract
Ling J et al.
What influences participation in clinical trials in palliative
care in a cancer centre? Eur J Cancer 2000;36(5):621-6.
Abstract
Pinto HA et
al. Physician perspectives on increasing minorities in cancer
clinical trials: An Eastern Cooperative Oncology Group (ECOG) Initiative.
Ann Epidemiol 2000;10(8 Suppl):S78-84. Abstract
Ruffin MT 4th,
Baron J. Recruiting subjects in cancer prevention and control
studies. J Cell Biochem Suppl 2000;34:80-3. Abstract
Siminoff LA
et al. Factors that predict the referral of breast cancer patients
onto clinical trials by their surgeons and medical oncologists.
J Clin Oncol 2000;18:1203-1211. Abstract
Sutherland HJ
et al. What attitudes and beliefs underlie patients' decisions
about participating in chemotherapy trials? Med Decis Making
1998;18(1):61-69. Abstract
Trauth JM et
al. Public attitudes regarding willingness to participate in
medical research studies. J Health Soc Policy 2000;12(2):23-43.
Abstract
Wagner JL et
al. Incremental costs of enrolling cancer patients in clinical
trials: A population-based study. J Natl Cancer Inst 1999;91(10):847-53.
Abstract
Top
OTHER
RESOURCES
NCI Cancer
Trials Support Unit (CTSU): Support for physicians and patients
to participate in NCI-sponsored phase III cancer treatment trials
Web link
NCI CancerNet:
Search for Clinical Trials (PDQ®) Web
link
Early Breast
Cancer Trialists' Collaborative Group (EBCTCG) Web
link
Top
Additional
Sections:
1 | 2
| 3 | 4
| 5 | 6
| 7 | 8
| 9 | 10
| 11 | 12
|
|